Article Details

Plasmagen Biosciences taps into niche Indian biopharma market with launch of CSL's ...

Retrieved on: 2024-06-20 13:12:52

Tags for this article:

Click the tags to see associated articles and topics

Plasmagen Biosciences taps into niche Indian biopharma market with launch of CSL's .... View article details on hiswai:

Excerpt

Haemocomplettan® P will cater to the 1,50,000 cardiac surgeries and over 1,800 liver transplant patients. Plasmagen Biosciences, headquartered in ...

Article found on: www.biospectrumindia.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up